Sakon Earns EcoVadis Committed Badge for Sustainability Performance 
Bring Your Toughest AM Quality Problem To Formnext: Amsight Challenges Manufacturers To Rethink Production Quality Radius Health, Inc. Provides Abaloparatide Business Update
17% growth in January 2021 for new TYMLOS® patients vs. previous 4 month trailing average…
New Positive Phase 1/2 Interim Data Presented at WORLDSymposium™ Shows Neurocognitive Development of Young MPS IIIA Patients Preserved up to Three Years Following Treatment with Abeona’s ABO-102 Gene Therapy
In addition to preservation of neurocognitive development with ABO-102 in MPS IIIA, new clinical results…
Tauriga Sciences Inc. to Commence Development of its 1st Full Spectrum CBD Infused Edibles Product Line
NEW YORK, NY , Feb. 12, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Tauriga Sciences, Inc….
Trading in Novo Nordisk shares by board members, executives and associated persons on 11-12 February 2021
Bagsværd, Denmark, 12 February 2021 — This document discloses the data of the transaction(s) made…
Delisting of AS „Grindeks” shares from the Baltic Main list
Delisting of AS „Grindeks” shares from the Baltic Main list Joint Stock Company “Grindeks” hereby…
Revive Therapeutics Announces Closing of $23.0 Million Short Form Prospectus Offering
TORONTO, Feb. 12, 2021 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE:RVV)…
Shattuck Labs Announces Participation in Citi’s 2021 Virtual Immuno-Oncology Day
AUSTIN, TX & DURHAM, NC, Feb. 12, 2021 (GLOBE NEWSWIRE) — Shattuck Labs, Inc. (Shattuck)…
Oyster Point Pharma to Report Fourth Quarter and Full Year 2020 Financial Results on February 18, 2021
Conference Call and Webcast Scheduled for February 18, 2021, 4:30 pm ET PRINCETON, N.J., Feb….
Corvus Pharmaceuticals Announces Pricing of Public Offering of Common Stock
BURLINGAME, Calif., Feb. 12, 2021 (GLOBE NEWSWIRE) — Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS), a clinical-stage biopharmaceutical…
Cronos Group Inc. to Hold 2020 Fourth Quarter and Full-Year Earnings Conference Call on February 26, 2021
TORONTO, Feb. 12, 2021 (GLOBE NEWSWIRE) — Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos…
Quotient Limited Participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
JERSEY, Channel Islands, Feb. 12, 2021 (GLOBE NEWSWIRE) — Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics…
Vistin Pharma ASA: Invitation to Q4 2020 conference call
Oslo, Norway, 12 February 2020 Vistin Pharma ASA will release its fourth quarter 2020 results…
Vericel Announces Termination of Shareholder Rights Agreement
CAMBRIDGE, Mass., Feb. 12, 2021 (GLOBE NEWSWIRE) — Vericel Corporation (NASDAQ:VCEL), a leader in advanced…
Pfizer and BioNTech to Supply the United States with 100 Million Additional Doses of COVID-19 Vaccine
U.S. government exercises option to bring total supply to 300 million doses, enabling vaccinations for…
George Archos Reports Holdings in Verano Holdings Corp.
TORONTO, Feb. 12, 2021 (GLOBE NEWSWIRE) — George Archos (the “Acquiror”), the Chairman, CEO and…
Caladrius Biosciences, Inc. Announces $65 Million Registered Direct Offerings Priced At-The-Market under Nasdaq Rules
BASKING RIDGE, N.J., Feb. 12, 2021 (GLOBE NEWSWIRE) — Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius”…
Jounce Therapeutics Appoints Luisa Salter-Cid, Ph.D., to its Board of Directors
CAMBRIDGE, Mass., Feb. 12, 2021 (GLOBE NEWSWIRE) — Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage…
BridgeBio Pharma, Inc. Announces Pricing of Secondary Offering of Common Stock
PALO ALTO, Calif. , Feb. 12, 2021 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO)…
Denali Therapeutics Reports Positive Three-Month Data from Phase 1/2 Study with ETV:IDS (DNL310) in Patients with Hunter Syndrome (MPS II)
Sustained normalization and further decreased levels of CSF glycosaminoglycan heparan sulfate, a key CNS disease…
SMFM Conference and Publications Highlight the Challenges and Complexities of Diagnosing and Managing Preeclampsia
Progenity applauds focus on preeclampsia biomarkers as it prepares for the launch of the Preecludia™…